Debora Jorn

Filings by Debora Jorn span 2 companies, the busiest being Viveve Medical, Inc. and Valeant Pharmaceuticals International, Inc. In total, 12 filings cover trades dated from 20 November 2015 to 1 April 2019.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Most recently, on 3 April 2019, the filings show a share grant in Viveve Medical, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.